BIBLIOGRAPHIE 1. Ziol, M., et al., Non-invasive assessment of liver fibrosis by stiffness measurement: a prospective multicentre study in patients with chronic hepatitis C. Hepatology, 2005. 41(1): p. 48-54. 2. Marcellin, P., et al.,Non-invasive assessment of liverfibrosis by stiffness measurement in patients with chronic hepatitis B. Liver International, 2009. 29(2): p. 242-247. 3. Chan, H.L., et al., Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. Journal of viral hepatitis, 2009. 16(1): p. 36-44. 4. Vergara, S., et al., The use of transient elastometry for assessingliverbrosis in patients with HIVfi and hepatitisC virus coinfection. Clinical Infectious Diseases, 2007.45(8): p. 969-74. 5. Nguyen-Khac, E., et al., Assessmnt of asypmtome atic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with7non-invasive laboratory tests. Alimentary Pharmacology & Therapeutics, 2008.28(10): p. 1188-98. 6. Melin, P., et al., Dépistage non invasif de la fibrose : Intérêt du FibroScan en consultation® d’alcoologierest of FibroScan in alcohol addiction®e [Noninvasive screening of fibrosis: int consultation]. Alcoologie et Addictologie, 2005. 27(3): p. 191-196. 7. Musso, G., et al., Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Annals of Medicine, 2010.2011. 43(8):617-49. 8. de Ledinghen, V., et al., Feasibility of liver transient elastography with FibroScan(R) using a new probe for obese patients. Liver International, 2010. 30(7): p. 1043-1048. 9. Corpechot, C., et al., Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology, 2006. 43(5): p. 1118-1124. 10. Friedrich-Rust, M., et al., Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology, 2008. 134(4): p. 960-74. 11.Arima, Y., et al., Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitisC. Hepatology Research, 2010. 40(4): p. 383-92. 12. Malik, R., et al., Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis. Journal of Gastroenterology & Hepatology, 2010. 25(9):p. 1562- 8. 13. Vizzutti, F., et al., Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology, 2007. 45(5): p. 1290-7. 14. Masuzaki, R., et al., Prospective risk assessment for hepatocellular carcinoma development in patients with chronichepatitis C by transient elastography. Hepatology, 2009. 49(10): p. 1954-61. 15. Rigamonti, C., M.F. Donato, and M. Colombo, Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation. Hepatology, 2010. 52(2): p. 800-1. 16. Carrión, J.A., et al., Liver stiffness identifies two different patterns of fibrosis progression in patientswith HCV recurrence after liver transplantation. Hepatology, 2010. 51(1): p. 23-34. 17.Laharie, D., et al., Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case-control study. Journal of Hepatology, 2010.53(6): p. 1035-40. 18. Roulot, D., et al., Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population over 45 years. Gut, 2010. 60(7):977-84. 19. Foucher, J., et al., FibroScan used in street-based outreach for drug users is useful for hepatitis C® virus screening and management: a prospective study. Journal of Viral Hepatitis, 2009. 16(2): p. 121- 31. 20. Menten, R., et al., Transient elastography in patients with cystic fibrosis. Pediatric Radiology, 2010. 40(7): p. 1231-5. 21. Nobili, V., et al., Accuracy and reproducibility of transient elastographyfor the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology, 2008.48(2): p. 442-8. 22. Bonnard, P., et al., Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. The American Journal of Tropical Medicine and Hygiene, 2010. 82(3): p. 454-8. 23. Sasso, M., et al., Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis - Preliminarystudy and validation in a cohort of patints with chronie c liver disease from various causes. Ultrasound in Medicine and Biology, 2010. 36(11): p. 1825-1835. 24.Myers, R.P., et al., Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver International, 2012. 32(6): p. 902-10. 25. de Ledinghen, V., et al., Non-invasive diagnosis of liver steatosiusing cons trolled attenuation parameter (CAP) and transient elastography. Liver Int, 2012.32(6): p. 911-8. 26. Sasso, M., et al., Novel Controlled Attenuation Parameter (CAP) for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C. Journal of Viral Hepatitis, 2012. 36(1): p. 73-20. 27.Vergniol, J., et al., Non-Invasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients with Chronic HepatitisC. Gastroenterology, 2011. 140(7):1970-9, 1979.